DNMT3B and T-cell non-Hodgkin lymphoma: Such molecular change may contribute to the pathogenesis of PTCL in particular because Dnmt3b loss accelerates MYC-induced lymphomagenesis as well as promotes the development of T cell lymphomas in Dnmt3aΔ/Δ mice9, 12.